We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+7.29%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$22.1B
AUM Growth
+$302M
Cap. Flow
-$1.3B
Cap. Flow %
-5.9%
Top 10 Hldgs %
11.41%
Holding
3,562
New
1,146
Increased
641
Reduced
606
Closed
971

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$148M
2
NFLX icon
Netflix
NFLX
+$119M
3
ABNB icon
Airbnb
ABNB
+$111M
4
XYZ
Block Inc
XYZ
+$89.5M
5
DHR icon
Danaher
DHR
+$88.6M

Top Sells

Rank Stock Value
1
CRL icon
Charles River Laboratories
CRL
+$212M
2
BABA icon
Alibaba
BABA
+$172M
3
ZTS icon
Zoetis
ZTS
+$133M
4
TRU icon
TransUnion
TRU
+$124M
5
BIDU icon
Baidu
BIDU
+$111M

Sector Composition

Rank Sector Weight
1 Healthcare 20.88%
2 Financials 13.4%
3 Consumer Discretionary 12.06%
4 Technology 11.2%
5 Communication Services 8.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TFX icon
1
Teleflex
TFX
$5.85B
$369M 1.67%
917,743
+151,813
+20% +$62.2M
MSFT icon
2
Microsoft
MSFT
$2.84T
$286M 1.29%
1,055,909
-208,409
-16% -$53M
AMZN icon
3
Amazon
AMZN
$2.5T
$280M 1.27%
1,629,920
-46,140
-3% -$7.67M
BIO icon
4
Bio-Rad Laboratories Class A
BIO
$8.42B
$280M 1.27%
435,099
-133,819
-24% -$81.4M
BHVN
5
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$265M 1.2%
2,732,368
-44,099
-2% -$3.58M
TMO icon
6
Thermo Fisher Scientific
TMO
$211B
$252M 1.14%
500,167
+60,052
+14% +$28.3M
BIIB icon
7
Biogen
BIIB
$29.9B
$226M 1.02%
651,320
+488,764
+301% +$148M
PARA
8
DELISTED
Paramount Global Class B
PARA
$208M 0.94%
4,612,007
-1,324,487
-22% -$54.7M
AAPL icon
9
Apple
AAPL
$4.89T
$179M 0.81%
1,308,735
+13,613
+1% +$1.76M
ZTS icon
10
Zoetis
ZTS
$31.6B
$177M 0.8%
951,285
-767,090
-45% -$133M
IWM icon
11
CALL
iShares Russell 2000 ETF
IWM
$80.9B
$152M 0.69%
663,000
-253,800
-28% -$57.1M
ABNB icon
12
Airbnb
ABNB
$83.7B
$147M 0.67%
960,722
+707,818
+280% +$111M
NTRA icon
13
Natera
NTRA
$37.5B
$144M 0.65%
1,268,144
+94,131
+8% +$9.63M
RGEN icon
14
Repligen
RGEN
$7.44B
$140M 0.63%
702,914
-240,810
-26% -$46.7M
IWM icon
15
PUT
iShares Russell 2000 ETF
IWM
$80.9B
$135M 0.61%
588,800
-114,700
-16% -$25.8M
TWST icon
16
Twist Bioscience
TWST
$5.62B
$135M 0.61%
1,011,853
+157,341
+18% +$18.3M
DHR icon
17
Danaher
DHR
$135B
$132M 0.6%
553,678
+399,538
+259% +$88.6M
NFLX icon
18
Netflix
NFLX
$292B
$129M 0.58%
2,448,560
+2,325,800
+1,895% +$119M
NSTG
19
DELISTED
NanoString Technologies, Inc.
NSTG
$123M 0.55%
1,891,380
+138,761
+8% +$8.81M
GLD icon
20
PUT
SPDR Gold Trust
GLD
$131B
$122M 0.55%
739,500
+707,800
+2,233% +$120M
MNST icon
21
Monster Beverage
MNST
$91.4B
$120M 0.54%
2,637,788
+193,328
+8% +$9.07M
CRM icon
22
Salesforce
CRM
$134B
$113M 0.51%
464,208
+297,776
+179% +$68.6M
ITCI
23
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$113M 0.51%
2,771,304
-63,156
-2% -$2.33M
XYZ
24
Block Inc
XYZ
$45.9B
$112M 0.5%
457,952
+385,685
+534% +$89.5M
VRTX icon
25
Vertex Pharmaceuticals
VRTX
$121B
$111M 0.5%
550,959
+364,231
+195% +$76.2M
1
2 3 4 5

Similar funds

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $94.5B AUM 29.33% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Marshall Wace's Q2 2021 Portfolio in Review

As of Q2 2021, Marshall Wace held 3,562 positions worth $22.1B, up 1.4% from $21.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Marshall Wace withdrew a net $1.3B in Q2 2021, closing 971 positions and reducing 606 holdings. Its most notable exit was Pinterest, an estimated $88.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Marshall Wace opened a new position in West Pharmaceutical worth $55.8M.

  • Marshall Wace's largest Q2 2021 buy was West Pharmaceutical: 155,316 shares worth $55.8M.
  • Marshall Wace added most to Biogen in Q2 2021, an estimated $148M increase.
  • Marshall Wace's biggest Q2 2021 reduction was Charles River Laboratories, cutting an estimated $212M.
  • Marshall Wace fully exited Pinterest in Q2 2021, selling an estimated $88.8M.
  • Marshall Wace's ten largest holdings make up 11% of its $22.1B portfolio in Q2 2021.
  • Marshall Wace opened 1,146 new positions and closed 971 in Q2 2021.
  • Marshall Wace's portfolio value rose 1.4% quarter-over-quarter to $22.1B.

Based on Marshall Wace's 13F filing for Q2 2021, filed 13 Aug 2021.